Traws Pharma, Inc. - Director's Dealing 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-30

Reporting Person: Reddy E Premkumar (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-07-30	Common Stock	C	13923	—	Acquired	1201548	Direct
2013-07-30	Common Stock	C	19569	—	Acquired	1221117	Direct
2013-07-30	Common Stock	C	737	—	Acquired	1221854	Direct
2013-07-30	Common Stock	C	16573	—	Acquired	1238427	Direct
2013-07-30	Common Stock	C	3842	—	Acquired	1242269	Direct
2013-07-30	Common Stock	C	7708	—	Acquired	1249977	Direct
2013-07-30	Common Stock	C	1225	—	Acquired	1251202	Direct
2013-07-30	Common Stock	C	766	—	Acquired	1251968	Direct
2013-07-30	Common Stock	C	750	—	Acquired	1252718	Direct
2013-07-30	Common Stock	P	20000	$15.00	Acquired	1272718	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Underlying	Ownership
2013-07-30	Series A Convertible Preferred Stock	$	C	17333	Disposed	Common Stock (13923)	Direct
2013-07-30	Series B Convertible Preferred Stock	$	C	23187	Disposed	Common Stock (19569)	Direct
2013-07-30	Series C Convertible Preferred Stock	$	C	983	Disposed	Common Stock (737)	Direct
2013-07-30	Series D Convertible Preferred Stock	$	C	22093	Disposed	Common Stock (16573)	Direct
2013-07-30	Series E Covertible Preferred Stock	$	C	5124	Disposed	Common Stock (3842)	Direct
2013-07-30	Series F Convertible Preferred Stock	$	C	10000	Disposed	Common Stock (7708)	Direct
2013-07-30	Series G Convertible Preferred Stock	$	C	1634	Disposed	Common Stock (1225)	Direct
2013-07-30	Series H COnvertible Preferred Stock	$	C	1022	Disposed	Common Stock (766)	Direct
2013-07-30	Series I Convertible Preferred Stock	$	C	1001	Disposed	Common Stock (750)	Direct

F1: The Series A Convertible Preferred Stock converted into Common Stock on a 0.80-for-1 basis and had no expiration date.

F2: The Series B Convertible Preferred Stock converted into Common Stock on a 0.85-for-1 basis and had no expiration date.

F3: The Series C Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F4: The Series D Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F5: The Series E Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F6: The Series F Convertible Preferred Stock converted into Common Stock on a 0.77-for-1 basis and had no expiration date.

F7: The Series G Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F8: The Series H Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F9: The Series I Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.